The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors. - sprookjes - yvandenbroek - TriplyDB

The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors.

The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors.

http://www.wikidata.org/entity/Q37729290

about

Differentiated Thyroid Cancer-Treatment: State of the Art.Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma.Current Knowledge in Thyroid Cancer-From Bench to Bedside.Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma.Target Identification of Kinase Inhibitor Alisertib (MLN8237) by Using DNA-Programmed Affinity Labeling.Semantic Analysis of Posttranslational Modification of Proteins Accumulated in Thyroid Cancer Cells Exposed to Simulated Microgravity Thyroid cancer cells in space during the TEXUS-53 sounding rocket mission - The THYROID Project Focal segmental glomerulosclerosis lesion associated with inhibition of tyrosine kinases by lenvatinib: a case report

P2860

Q33839037-F01C86CC-629E-4702-8205-DB011F86BDA5 Q41573990-3BE19D0A-B0D5-47D4-A110-E0FA4A785A63 Q42340016-1823E7F8-D676-4807-8C75-62FF8D1C4296 Q47923729-0F3C67D9-4FBB-4396-9F97-C767ABE36AC5 Q48307732-3314BC2C-28C2-4350-A26C-36907EC896B3 Q56815367-54267CD1-95C7-4A5C-BAF1-7990E909CEDA Q57672611-F61D0463-C411-4A62-9D5C-4588FDC8BA91 Q57809492-5DBF8A32-6FCE-4261-97A3-17EB7CB5B9CC

P2860

The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors.

http://www.wikidata.org/entity/Q37729290

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Adverse Effect of Hyperten ...... with Multi-Kinase Inhibitors.

@en

The Adverse Effect of Hyperten ...... with Multi-Kinase Inhibitors.

@nl

type

label

The Adverse Effect of Hyperten ...... with Multi-Kinase Inhibitors.

@en

The Adverse Effect of Hyperten ...... with Multi-Kinase Inhibitors.

@nl

prefLabel

The Adverse Effect of Hyperten ...... with Multi-Kinase Inhibitors.

@en

The Adverse Effect of Hyperten ...... with Multi-Kinase Inhibitors.

@nl

P1433

Q37729290-C62134F7-20C8-487F-80DD-17048C3EACF5

P1476

Q37729290-0006E035-77E8-46A8-840D-02C0E28C5518

P2093

Q37729290-0EE064FA-AEF7-49E4-B737-C3BC136DA9DD

Q37729290-608B80EC-102D-4063-A7E4-CA9C28D7ED16

Q37729290-C7BA36FC-0D6B-45EC-AF32-8F8B4D231385

Q37729290-F6633060-63D0-49AE-BD63-AFD7CC447ADD

P275

Q37729290-3133A6E7-0902-43E5-9121-159D32C39ADA

P2860

Q37729290-031DB01A-D3BE-49B0-9E9D-C53DF4F6609B

Q37729290-03DA4826-B62A-40F9-8B62-39A34D681CFF

Q37729290-065F9BA0-98B1-45CA-A85F-A0766AFF5A62

Q37729290-07A8D94A-03E0-44E2-BF7C-F4793F657045

Q37729290-09420EE9-CCF8-4E74-AF97-6E708553999A

Q37729290-09DDDB72-6858-4F86-92C3-01A3927EE110

Q37729290-0C45D966-E7FE-4356-A49D-A70FD8DA418C

Q37729290-0CB71AD3-ACB2-43E8-981B-1564998A28BD

Q37729290-0EC31041-BB8A-409B-B89C-E55E4A55AFD9

Q37729290-15433190-85BD-478A-BE56-9D70A79F5FE1

P31

Q37729290-81E0A17A-27B3-4DC8-B93D-A2AC08C562A1

Q37729290-D49C97E5-5E4C-4779-B8D5-7E6195908487

P356

Q37729290-5A4793CA-0B47-43BC-A36B-3424FB04EC9F

P407

Q37729290-B133019C-BB93-490C-A66D-F3A2345D0CBF

P433

Q37729290-3680C2F3-5FC1-43BC-A60C-EF3F46DDB686

P478

Q37729290-33D4CF04-2BE2-4F31-A515-4B19E0E8DD92

P50

Q37729290-D4C75ABD-7EA0-480B-A80E-970839425F1D

P5008

Q37729290-8A8BE5CF-2253-4ECD-BE0D-601D81E405B2

P577

Q37729290-E24880A0-FD2C-4838-8EB7-0774FAA23FCA

P698

Q37729290-2321E508-621E-4784-A9E5-EBB84CA78C0F

P921

Q37729290-5EB71BB4-4582-45EC-8839-7DE14266348C

Q37729290-A45B8D90-3A25-4DE3-BC6A-37A77C2E9187

Q37729290-F2F3CF46-2C96-42D3-A85C-A347D20DB162

Q37729290-F8996C7D-A65A-4523-9028-2B2A86385785

P932

Q37729290-D15F650F-7CE0-4E4E-80D9-CECCA7EB67DD

P356

P1433

International Journal of Molecular Sciences

P1476

The Adverse Effect of Hyperten ...... with Multi-Kinase Inhibitors.

@en

P2093

Daniela Grimm

http://www.w3.org/2001/XMLSchema#string

Johann Bauer

http://www.w3.org/2001/XMLSchema#string

Manfred Infanger

http://www.w3.org/2001/XMLSchema#string

Ole Vincent Ancker

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib

Lenvatinib: Role in thyroid cancer and other solid tumors

Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib

Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failure

Anti-vascular endothelial growth factor therapy in breast cancer

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor.

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

P31

scholarly article

P356

10.3390/IJMS18030625

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2017-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28335429

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

arterial hypertension

P932

5372639

http://www.w3.org/2001/XMLSchema#string